EHRA/HRS/APHRS expert consensus on ventricular arrhythmias

Europace

Volumn 16, Issue 9, 2014, Pages 1257-1283

  Pedersen, Christian Torp ^a   Kay, G Neal ^a   Kalman, Jonathan ^a   Borggrefe, Martin ^a   Della Bella, Paolo ^a   Dickfeld, Timm ^a   Dorian, Paul ^a   Huikuri, Heikki ^a   Kim, Youg Hoon ^a   Knight, Bradley ^a   Marchlinski, Francis ^a   Ross, David ^a   Sacher, Frédéric ^a   Sapp, John ^a   Shivkumar, Kalyanam ^a   Soejima, Kyoko ^a   Tada, Hiroshi ^a   Alexander, Mark E ^a   Triedman, John K ^a   Yamada, Takumi ^a   Kirchhof, Paulus ^a   Peachey, Hannah ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT;

ADRENERGIC STIMULATION; AMBULATORY MONITORING; AMYLOIDOSIS; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIAC IMAGING; CARDIAC PATIENT; CATHETER ABLATION; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; CONSENSUS; ELECTROCARDIOGRAM; EXERCISE TEST; HEART MUSCLE ISCHEMIA; HEART PAPILLARY MUSCLE; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FUNCTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MEDICAL SOCIETY; MONOMORPHIC VENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SARCOIDOSIS; SUDDEN CARDIAC DEATH; ARTICLE; CARDIOMYOPATHY; CHILDHOOD DISEASE; DRUG THERAPY; ELECTROPHYSIOLOGY; HEART; HEART ARREST; HEART DISEASE; HEART STIMULATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; IDIOPATHIC DISEASE; IDIOPATHIC VENTRICULAR TACHYCARDIA; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IMPLANTATION; INFANT DISEASE; ISCHEMIA; LEFT VENTRICULAR ASSIST DEVICE; NON SUSTAINED VENTRICULAR TACHYCARDIA; PACEMAKER IMPLANTATION; POLYMORPHIC VENTRICULAR TACHYCARDIA; PREMATURE VENTRICULAR COMPLEX; RESUSCITATION; SIGNAL AVERAGED ELECTROCARDIOGRAM; SURVIVOR; SUSTAINED MONOMORPHIC VENTRICULAR TACHYCARDIA; SUSTAINED POLYMORPHIC VENTRICULAR TACHYCARDIA; CARDIOVERSION; DIAGNOSTIC IMAGING; ELECTROCARDIOGRAPHY; EUROPE; HEART PACING; INTERNATIONAL COOPERATION; PRACTICE GUIDELINE; STANDARDS; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

CARDIAC PACING, ARTIFICIAL; DIAGNOSTIC IMAGING; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; EUROPE; HUMANS; INTERNATIONALITY; PRACTICE GUIDELINES AS TOPIC; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 84906976974     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu194     Document Type: Review

References (302)

1. Epstein AE, DiMarco JP, Ellenbogen KA, EstesNA III, Freedman RA, Gettes LS et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College Of Cardiology/American Heart Association task force onpractice guidelines (writing committee to revise the acc/aha/naspe 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008;117:e350-408. (Pubitemid 351771339)
2. Epstein AE, DiMarco JP, Ellenbogen KA, EstesNA III, Freedman RA, Gettes LS et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2013;127:e283-352.
3. Aliot EM, Stevenson WG, Almendral-Garrote JM, Bogun F, Calkins CH, Delacretaz E et al. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Europace 2009;11:771-817.
4. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace 2013;10:1932-63.
5. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace 2011;13:1077-109.
6. Garratt CJ, Elliott P, Behr E, Camm AJ, Cowan C, Cruickshank S et al. Heart Rhythm UK position statement on clinical indications for implantable cardioverter defibrillators in adult patients with familial sudden cardiac death syndromes. Europace 2010;12:1156-75.
7. Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N et al. ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010;31:2915-57.
8. Goldschlager N, Epstein AE, Naccarelli GV, Olshansky B, Singh B, Collard HR et al. A practical guide for clinicians who treat patients with amiodarone: 2007. Heart Rhythm 2007;4:1250-9. (Pubitemid 47324134)
9. Braunschweig F, Boriani G, Bauer A, Hatala R, Herrmann-Lingen C, Kautzner J et al. Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management. Europace 2010;12:1673-90.
10. Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009;30:2631-71.
11. Lampert R, Hayes DL, Annas GJ, Farley MA, Goldstein NE, Hamilton RM et al. American Heart A. HRS expert consensus statement on the management of cardiovascular implantable electronic devices (cieds) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm 2010;7:1008-26.
12. Jacobs AK, Kushner FG, Ettinger SM, Guyton RA, Anderson JL, Ohman EM et al. ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013;127:268-310.
13. Barsky AJ, Ahern DK, Bailey ED, Delamater BA. Predictors of persistent palpitations and continued medical utilization. J Fam Pract 1996;42:465-72. (Pubitemid 26158973)
14. Lee V, Hemingway H, Harb R, Crake T, Lambiase P. The prognostic significance of premature ventricular complexes in adults without clinically apparent heart disease: a meta-analysis and systematic review. Heart 2012;98:1290-8.
15. Ruberman W, Weinblatt E, Goldberg JD, Frank CW, Shapiro S. Ventricular premature beats and mortality after myocardial infarction. N Engl J Med 1977;297:750-7. (Pubitemid 8201636)
16. Bigger JT Jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984;69:250-8. (Pubitemid 14180330)
17. Bikkina M, Larson MG, Levy D. Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy. J Am Coll Cardiol 1993;22:1111-6. (Pubitemid 23285763)
18. Huikuri HV, Makikallio TH, Raatikainen MJ, Perkiomaki J, Castellanos A, Myerburg RJ. Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death. Circulation 2003;108:110-5. (Pubitemid 36859029)
19. Teerlink JR, Jalaluddin M, Anderson S, Kukin ML, Eichhorn EJ, Francis G et al.; PROMISE (Prospective Randomized Milrinone Survival Evaluation) investigators. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. Circulation 2000;101:40-6. (Pubitemid 30039074)
20. Yarlagadda RK, Iwai S, Stein KM, Markowitz SM, Shah BK, Cheung JW et al. Reversal of cardiomyopathy in patients with repetitive monomorphic ventricular ectopy originating from the right ventricular outflow tract. Circulation 2005;112:1092-7. (Pubitemid 41216114)
21. Bogun F, Crawford T, Reich S, Koelling TM, Armstrong W, Good E et al. Radiofrequency ablation of frequent, idiopathic premature ventricular complexes: comparison with a control group without intervention. Heart Rhythm 2007;4:863-7. (Pubitemid 46959198)
22. Ban JE, Park HC, Park JS, Nagamoto Y, Choi JI, Lim HE et al. Electrocardiographic and electrophysiological characteristics of premature ventricular complexes associated with left ventricular dysfunction in patients without structural heart disease. Europace 2013;15:735-41.
23. Sarrazin JF, Labounty T, Kuhne M, Crawford T, Armstrong WF, Desjardins B et al. Impact of radiofrequency ablation of frequent post-infarction premature ventricular complexes on left ventricular ejection fraction. Heart Rhythm 2009;6:1543-9.
24. Mountantonakis SE, Frankel DS, Gerstenfeld EP, Dixit S, Lin D, Hutchinson MD et al. Reversal of outflow tract ventricular premature depolarization- induced cardiomyopathy with ablation: effect of residual arrhythmia burden and preexisting cardiomyopathy on outcome. Heart Rhythm 2011;8:1608-14.
25. Ban JE, Park HC, Park JS, Nagamoto Y, Choi JI, Lim HE et al. Electrocardiographic and electrophysiological characteristics of premature ventricular complexes associated with left ventricular dysfunction in patients without structural heart disease. Europace 2013;15:735-41.
26. Deyell MW, Park KM, Han Y, Frankel DS, Dixit S, Cooper JM et al. Predictors of recovery of left ventricular dysfunction after ablation of frequent ventricular premature depolarizations. Heart Rhythm 2012;9:1465-72.
27. Del Carpio Munoz F, Syed FF, Noheria A, Cha YM, Friedman PA, Hammill SC et al. Characteristics of premature ventricular complexes as correlates of reduced left ventricular systolic function: study of the burden, duration, coupling interval, morphology and site of origin of PVCS. J Cardiovasc Electrophysiol 2011;22:791-8.
28. Olgun H, Yokokawa M, Baman T, Kim HM, Armstrong W, Good E et al. The role of interpolation in pvc-induced cardiomyopathy. Heart Rhythm 2011;8:1046-9.
29. Hasdemir C, Ulucan C, Yavuzgil O, Yuksel A, Kartal Y, Simsek E et al. Tachycardia-induced cardiomyopathy in patients with idiopathic ventricular arrhythmias: the incidence, clinical and electrophysiologic characteristics, and the predictors. J Cardiovasc Electrophysiol 2011;22:663-8.
30. Baman TS, Lange DC, Ilg KJ, Gupta SK, Liu TY, Alguire C et al. Relationship between burden of premature ventricular complexes and left ventricular function. Heart Rhythm 2010;7:865-9.
31. Kanei Y, Friedman M, Ogawa N, Hanon S, Lam P, Schweitzer P. Frequent premature ventricular complexes originating from the right ventricular outflow tract are associated with left ventricular dysfunction. Ann Noninvasive Electrocardiol 2008;13:81-5. (Pubitemid 351143707)
32. Bogun FM, Desjardins B, Good E, Gupta S, Crawford T, Oral H et al. Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate. J Am Coll Cardiol 2009;53:1138-45.
33. Niwano S, Wakisaka Y, Niwano H, Fukaya H, Kurokawa S, Kiryu M et al. Prognostic significance of frequent premature ventricular contractions originating from the ventricular outflow tract in patients with normal left ventricular function. Heart 2009;95:1230-7.
34. Kostis JB, McCrone K, Moreyra AE, Gotzoyannis S, Aglitz NM, Natarajan N et al. Premature ventricular complexes in the absence of identifiable heart disease. Circulation 1981;63:1351-6. (Pubitemid 11120673)
35. Brodsky M, Wu D, Denes P, Kanakis C, Rosen KM. Arrhythmias documented by 24 h continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease. Am J Cardiol 1977;39:390-5. (Pubitemid 8055354)
36. Viskin S, Rosso R, Rogowski O, Belhassen B. The 'short-coupled' variant of right ventricular outflow ventricular tachycardia: a not-so-benign form of benign ventricular tachycardia?. J Cardiovasc Electrophysiol 2005;16:912-6. (Pubitemid 41623785)
37. Aquaro GD, Pingitore A, Strata E, Di Bella G, Molinaro S, Lombardi M. Cardiac magnetic resonance predicts outcome in patients with premature ventricular complexes of left bundle branch block morphology. J Am Coll Cardiol 2010;56:1235-43.
38. Marcus FI, Bluemke DA, Calkins H, Sorrell VL. Cardiac magnetic resonance for risk stratification of patients with frequent premature ventricular contractions. J Am Coll Cardiol 2011;57:1636-7; author reply 1637-1638.
39. Bomma C, Rutberg J, Tandri H, Nasir K, Roguin A, Tichnell C et al. Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiovasc Electrophysiol 2004;15:300-6. (Pubitemid 38429444)
40. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Eur Heart J 2010;31:806-14.
41. Lakkireddy D, Di Biase L, Ryschon K, Biria M, Swarup V, Reddy YM et al. Radiofrequency ablation of premature ventricular ectopy improves the efficacy of cardiac resynchronization therapy in nonresponders. J Am Coll Cardiol 2012;60:1531-9.
42. Stec S, Sikorska A, Zaborska B, Krynski T, Szymot J, Kulakowski P. Benign symptomatic premature ventricular complexes: short- and long-termefficacy of antiarrhythmic drugs and radiofrequency ablation. Kardiol Pol 2012;70:351-8.
43. Krittayaphong R, Bhuripanyo K, Punlee K, Kangkagate C, Chaithiraphan S. Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study. Am Heart J 2002;144:e10.
44. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med 1991;324:781-8.
45. Joshi S, Wilber DJ. Ablation of idiopathic right ventricular outflow tract tachycardia: current perspectives. J Cardiovasc Electrophysiol 2005;16(Suppl 1):S52-8. (Pubitemid 44914770)
46. Ouyang F, Fotuhi P, Ho SY, Hebe J, Volkmer M, Goya M et al. Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation. J Am Coll Cardiol 2002;39:500-8. (Pubitemid 34117508)
47. Tada H, Ito S, Naito S, Kurosaki K, Kubota S, Sugiyasu A et al. Idiopathic ventricular arrhythmia arising from the mitral annulus: a distinct subgroup of idiopathic ventricular arrhythmias. J Am Coll Cardiol 2005;45:877-86. (Pubitemid 40342814)
48. Yamada T, McElderry HT, Doppalapudi H, Okada T, Murakami Y, Yoshida Y et al. Idiopathic ventricular arrhythmias originating from the left ventricular summit: anatomic concepts relevant to ablation. Circ Arrhythm Electrophysiol 2010;3:616-23.
49. Tada H, Tadokoro K, Miyaji K, Ito S, Kurosaki K, Kaseno K et al. Idiopathic ventricular arrhythmias arising from the pulmonary artery: prevalence, characteristics, and topography of the arrhythmia origin. Heart Rhythm 2008;5:419-26.
50. Baman TS, Ilg KJ, Gupta SK, Good E, Chugh A, Jongnarangsin K et al. Mapping and ablation of epicardial idiopathic ventricular arrhythmias from within the coronary venous system. Circ Arrhythm Electrophysiol 2010;3:274-9.
51. Daniels DV, Lu YY, Morton JB, Santucci PA, Akar JG, Green A et al. Idiopathic epicardial left ventricular tachycardia originating remote from the sinus of valsalva: electrophysiological characteristics, catheter ablation, and identification from the 12-lead electrocardiogram. Circulation 2006;113:1659-66.
52. Wijnmaalen AP, Delgado V, Schalij MJ, van Huls van Taxis CF, Holman ER, Bax JJ et al. Beneficial effects of catheter ablation on left ventricular and right ventricular function in patients with frequent premature ventricular contractions and preserved ejection fraction. Heart 2010;96:1275-80.
53. Yamada T, Litovsky SH, Kay GN. The left ventricular ostium: an anatomic concept relevant to idiopathic ventricular arrhythmias. Circ Arrhythm Electrophysiol 2008;1:396-404.
54. Dixit S, Gerstenfeld EP, Callans DJ, Marchlinski FE. Electrocardiographic patterns of superior right ventricular outflow tract tachycardias: distinguishing septal and free-wall sites of origin. J Cardiovasc Electrophysiol 2003;14:1-7. (Pubitemid 36246714)
55. Betensky BP, Park RE, Marchlinski FE, Hutchinson MD, Garcia FC, Dixit S et al. The v(2) transition ratio: a new electrocardiographic criterion for distinguishing left from right ventricular outflow tract tachycardia origin. J Am Coll Cardiol 2011;57:2255-62.
56. Yamada T, McElderry HT, Doppalapudi H, Murakami Y, Yoshida Y, Yoshida N et al. Idiopathic ventricular arrhythmias originating from the aortic root prevalence, electrocardiographic and electrophysiologic characteristics, and results of radiofrequency catheter ablation. J Am Coll Cardiol 2008;52:139-47. (Pubitemid 351885443)
57. Dixit S, Gerstenfeld EP, Lin D, Callans DJ, Hsia HH, Nayak HM et al. Identification of distinct electrocardiographic patterns from the basal left ventricle: distinguishing medial and lateral sites of origin in patients with idiopathic ventricular tachycardia. Heart Rhythm 2005;2:485-91. (Pubitemid 40521361)
58. Tada H, Tadokoro K, Ito S, Naito S, Hashimoto T, Kaseno K et al. Idiopathic ventricular arrhythmias originating from the tricuspid annulus: prevalence, electrocardiographic characteristics, and results of radiofrequency catheter ablation. Heart Rhythm 2007;4:7-16. (Pubitemid 46002622)
59. Yamada T, Doppalapudi H, McElderry HT, Okada T, Murakami Y, Inden Y et al. Electrocardiographic and electrophysiological characteristics in idiopathic ventricular arrhythmias originating from the papillary muscles in the left ventricle: relevance for catheter ablation. Circ Arrhythm Electrophysiol 2010;3:324-31.
60. Katritsis DG, Camm AJ. Nonsustained ventricular tachycardia: where do we stand? Eur Heart J 2004;25:1093-9. (Pubitemid 38834067)
61. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8:746-837.
62. Katritsis DG, Zareba W, Camm AJ. Nonsustained ventricular tachycardia. J Am Coll Cardiol 2012;60:1993-2004.
63. Latif S, Dixit S, Callans DJ. Ventricular arrhythmias in normal hearts. Cardiol Clin 2008;26:367-80, vi. (Pubitemid 351758980)
64. Paudel B, Paudel K. The diagnostic significance of the Holter monitoring in the evaluation of palpitation. J Clin Diagn Res 2013;7:480-3.
65. Russo AM, Stainback RF, Bailey SR, Epstein AE, Heidenreich PA, Jessup M et al. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Heart Rhythm 2013;10:e11-58.
66. Jouven X, Zureik M, Desnos M, Courbon D, Ducimetiere P. Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations. N Engl J Med 2000;343:826-33.
67. Frolkis JP, Pothier CE, Blackstone EH, Lauer MS. Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med 2003;348:781-90. (Pubitemid 36245754)
68. Biffi A, Maron BJ, Di Giacinto B, Porcacchia P, Verdile L, Fernando F et al. Relation between training-induced left ventricular hypertrophy and risk for ventricular tachyarrhythmias in elite athletes. Am J Cardiol 2008;101:1792-5.
69. Biffi A, Pelliccia A, Verdile L, Fernando F, Spataro A, Caselli S et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol 2002;40:446-52. (Pubitemid 34833158)
70. Sauer AJ, Newton-Cheh C. Clinical and genetic determinants of torsade de pointes risk. Circulation 2012;125:1684-94.
71. Hohnloser SH, Al-Khalidi HR, Pratt CM, Brum JM, Tatla DS, Tchou P et al. Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial. Eur Heart J 2006;27:3027-32. (Pubitemid 44950447)
72. Nogami A, Naito S, Tada H, Taniguchi K, Okamoto Y, Nishimura S et al. Demonstration of diastolic and presystolic purkinje potentials as critical potentials in a macroreentry circuit of verapamil-sensitive idiopathic left ventricular tachycardia. J Am Coll Cardiol 2000;36:811-23.
73. Lahat H, Eldar M, Levy-Nissenbaum E, Bahan T, Friedman E, Khoury A et al. Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation 2001;103:2822-7. (Pubitemid 32550071)
74. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R et al. Mutations in the cardiac ryanodine receptor gene (hryr2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001;103:196-200. (Pubitemid 32095402)
75. Scirica BM, Braunwald E, Belardinelli L, Hedgepeth CM, Spinar J, Wang W et al. Relationship between nonsustained ventricular tachycardia after non-st-elevation acute coronary syndrome and sudden cardiac death: observations from the metabolic efficiency with ranolazine for less ischemia in non-st-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (merlin-timi 36) randomized controlled trial. Circulation 2010;122:455-62.
76. Chen T, Koene R, Benditt DG, Lü F. Ventricular ectopy in patients with left ventricular dysfunction: Should it be treated? J Card Fail 2013;19:40-9.
77. Chen J, Johnson G, Hellkamp AS, Anderson J, Mark DB, Lee KL et al. Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HEFT (sudden cardiac death in heart failure trial). J Am Coll Cardiol 2013;61:2161-8.
78. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP et al. Reduction in inappropriate therapy and mortality through icd programming. N Engl J Med 2012;367:2275-83.
79. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008;359:1009-17.
80. Doppalapudi H, Yamada T, McElderry HT, Plumb VJ, Epstein AE, Kay GN. Ventricular tachycardia originating from the posterior papillary muscle in the left ventricle: a distinct clinical syndrome. Circ Arrhythm Electrophysiol 2008;1:23-9.
81. Crawford T, Mueller G, Good E, Jongnarangsin K, Chugh A, Pelosi F Jr et al. Ventricular arrhythmias originating from papillary muscles in the right ventricle. Heart Rhythm 2010;7:725-30.
82. German LD, Packer DL, Bardy GH, Gallagher JJ. Ventricular tachycardia induced by atrial stimulation in patients without symptomatic cardiac disease. Am J Cardiol 1983;52:1202-7. (Pubitemid 14243973)
83. Morishima I, Nogami A, Tsuboi H, Sone T. Negative participation of the left posterior fascicle in the reentry circuit of verapamil-sensitive idiopathic left ventricular tachycardia. J Cardiovas Electrophysiol 2012;23:556-9.
84. van derWerf C, Zwinderman AH, Wilde AA. Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments. Europace 2012;14:175-83.
85. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37. (Pubitemid 40110811)
86. Moss AJ. What we have learned from the family of multicenter automatic defibrillator implantation trials. Circ J 2010;74:1038-41.
87. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83. (Pubitemid 34984635)
88. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al.; Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-40. (Pubitemid 26428217)
89. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN et al.; Multicenter Unsustained Tachycardia Trial Investigators. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl J Med 2000;342:1937-45. (Pubitemid 30419088)
90. Buxton AE, Calkins H, Callans DJ, DiMarco JP, Fisher JD, Greene HL et al. ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on clinical data standards (ACC/AHA/HRS writing committee to develop data standards on electrophysiology). Circulation 2006;114:2534-70. (Pubitemid 44913875)
91. Coggins DL, Lee RJ, Sweeney J, Chein WW, Van Hare G, Epstein L et al. Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin. J Am Coll Cardiol 1994;23:1333-41. (Pubitemid 24158001)
92. Morady F, Kadish AH, DiCarlo L, Kou WH, Winston S, deBuitlier M et al. Long-term results of catheter ablation of idiopathic right ventricular tachycardia. Circulation 1990;82:2093-9.
93. Sacher F, Tedrow UB, Field ME, Raymond JM, Koplan BA, Epstein LM et al. Ventricular tachycardia ablation: evolution of patients and procedures over 8 years. Circ Arrhythm Electrophysiol 2008;1:153-61.
94. Shimizu W. Arrhythmias originating from the right ventricular outflow tract: how to distinguish 'malignant' from 'benign'? Heart Rhythm 2009;6:1507-11.
95. Lampert R, Wang Y, Curtis JP. Variation among hospitals in selection of higher-cost, 'higher-tech,' implantable cardioverter-defibrillators: data from the National Cardiovascular Data Registry (NCDR) implantable cardioverter/defibrillator (ICD) registry. Am Heart J 2013;165:1015-23 e1012.
96. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS et al. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-302. (Pubitemid 30158618)
97. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-54. (Pubitemid 30648765)
98. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83.
99. Raitt MH, Renfroe EG, Epstein AE, McAnulty JH, Mounsey P, Steinberg JS et al. 'Stable' ventricular tachycardia is not a benign rhythm: insights from the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry. Circulation 2001;103:244-52. (Pubitemid 32095410)
100. Sweeney MO, Sherfesee L, DeGroot PJ, Wathen MS, Wilkoff BL. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 2010;7:353-60.
101. Dorian P, Hohnloser SH, Thorpe KE, Roberts RS, Kuck KH, Gent M et al. Mechanisms underlying the lack of effect of implantable cardioverter- defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: insights from the Defibrillation In Acute Myocardial Infarction Trial (DINAMIT). Circulation 2010;122:2645-52.
102. Goldenberg I, Moss AJ, Hall WJ, McNitt S, Zareba W, Andrews ML et al. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II. Circulation 2006;113:2810-7. (Pubitemid 44305293)
103. Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004;110:3760-5. (Pubitemid 40023973)
104. Dunbar SB, Dougherty CM, Sears SF, Carroll DL, Goldstein NE, Mark DB et al. Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association. Circulation 2012;126:2146-72.
105. Carbucicchio C, Santamaria M, Trevisi N, Maccabelli G, Giraldi F, Fassini G et al. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-termoutcomes in a prospective single-center study. Circulation 2008;117:462-9.
106. Izquierdo M, Ruiz-Granell R, Ferrero A, Martínez A, Sánchez-Gomez J, Bonanad C et al. Ablation orconservative management of electrical storm due tomonomorphic ventricular tachycardia: differences in outcome. Europace 2012;14:1734-9.
107. Vereckei A, Duray G, Szenasi G, Altemose GT, Miller JM. Application of a new algorithm in the differential diagnosis of wide QRS complex tachycardia. Eur Heart J 2007;28:589-600. (Pubitemid 47355500)
108. Akhtar M, Shenasa M, Jazayeri M, Caceres J, Tchou PJ. Wide qrs complex tachycardia. Reappraisal of a common clinical problem. Ann Intern Med 1988;109:905-12. (Pubitemid 19000031)
109. Wellens HJ, Bar FW, Lie KI. The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex. Am J Med 1978;64:27-33. (Pubitemid 8275240)
110. Vereckei A, Duray G, Szenasi G, Altemose GT, Miller JM. New algorithm using only lead AVR for differential diagnosis of wide QRS complex tachycardia. Heart Rhythm 2008;5:89-98.
111. Jastrzebski M, Kukla P, Czarnecka D, Kawecka-Jaszcz K. Comparison of five electrocardiographic methods for differentiation of wide QRS-complex tachycardias. Europace 2012;14:1165-71.
112. Ainsworth CD, Skanes AC, Klein GJ, Gula LJ, Yee R, Krahn AD. Differentiating arrhythmogenic right ventricular cardiomyopathy from right ventricular outflow tract ventricular tachycardia using multilead QRS duration and axis. Heart Rhythm 2006;3:416-23.
113. Yokokawa M, Liu TY, Yoshida K, Scott C, Hero A, Good E et al. Automated analysis of the 12-lead electrocardiogram to identify the exit site of postinfarction ventricular tachycardia. Heart Rhythm 2012;9:330-4.
114. Park KM, Kim YH, Marchlinski FE. Using the surface electrocardiogram to localize the origin of idiopathic ventricular tachycardia. Pacing Clin Electrophysiol 2012;35:1516-27.
115. Das MK, Khan B, Jacob S, Kumar A, Mahenthiran J. Significance of a fragmented QRS complex versus a q wave in patients with coronary artery disease. Circulation 2006;113:2495-501. (Pubitemid 43948027)
116. Das MK, Suradi H, Maskoun W, Michael MA, Shen C, Peng J et al. Fragmented wide QRS on a 12-lead ECG: a sign of myocardial scar and poor prognosis. Circ Arrhythm Electrophysiol 2008;1:258-68.
117. Zimmerman SL, Nazarian S. Cardiac MRI in the treatment of arrhythmias. Expert Rev Cardiovasc Ther 2013;11:843-51.
118. Gomes JA, Cain ME, Buxton AE, Josephson ME, Lee KL, Hafley GE. Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation 2001;104:436-41. (Pubitemid 32678274)
119. Bauer A, Guzik P, Barthel P, Schneider R, Ulm K, Watanabe MA et al. Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era. Eur Heart J 2005;26:755-61. (Pubitemid 40547077)
120. Kamath GS, Zareba W, Delaney J, Koneru JN, McKenna W, Gear K et al. Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/ dysplasia. Heart Rhythm 2011;8:256-62.
121. Wyse DG, Talajic M, Hafley GE, Buxton AE, Mitchell LB, Kus TK et al. Antiarrhythmic Drug Therapy in the Multicenter Unsustained Tachycardia Trial(MUSTT): drug testing and as-treated analysis. J Am Coll Cardiol 2001;38:344-51.
122. Corrado D, Basso C, Leoni L, Tokajuk B, Bauce B, Frigo G et al. Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2005;111:3042-50. (Pubitemid 40847780)
123. Migliore F, Zorzi A, Silvano M, Bevilacqua M, Leoni L, Marra MP et al. Prognostic value of endocardial voltage mapping in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circ Arrhythm Electrophysiol 2013;6:167-76.
124. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee to update the 1997 exercise testing guidelines). Circulation 2002;106:1883-92.
125. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL
126. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/ASNC Committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). Circulation 2003;108:1404-18.
127. Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA et al. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee on coronary angiography). Developed in collaboration with the society for cardiac angiography and interventions. J Am Coll Cardiol 1999;33:1756-824.
128. Dickfeld T, Kocher C. The role of integrated PET-CT scar maps for guiding ventricular tachycardia ablations. Curr Cardiol Repo 2008;10:149-57.
129. Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 2002;346:884-90. (Pubitemid 34984636)
130. Desouza IS, Martindale JL, Sinert R. Antidysrhythmic drug therapy for the termination of stable, monomorphic ventricular tachycardia: a systematic review. Emerg Med J 2013;68:392-7.
131. Buxton AE, Waxman HL, Marchlinski FE, Simson MB, Cassidy D, Josephson ME. Right ventricular tachycardia: clinical and electrophysiologic characteristics. Circulation 1983;68:917-27. (Pubitemid 14238468)
132. Gill JS, Mehta D, Ward DE, Camm AJ. Efficacy of flecainide, sotalol, and verapamil in the treatment of right ventricular tachycardia in patients without overt cardiac abnormality. Br Heart J 1992;68:392-7.
133. Hoffmayer KS, Gerstenfeld EP. Diagnosis and management of idiopathic ventricular tachycardia. Curr Probl Cardiol 2013;38:131-58.
134. Nakagawa H, Beckman KJ, McClelland JH, Wang X, Arruda M, Santoro I et al. Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by a Purkinje potential. Circulation 1993;88:2607-17. (Pubitemid 23360185)
135. Nogami A. Purkinje-related arrhythmias part i: monomorphic ventricular tachycardias. Pacing Clin Electrophysiol 2011;34:624-50.
136. Connolly SJ. Meta-analysis of antiarrhythmic drug trials. Am J Cardiol 1999;84:90R-3R.
137. Farre J, Romero J, Rubio JM, Ayala R, Castro-Dorticos J. Amiodarone and 'primary' prevention of sudden death: critical review of a decade of clinical trials. Am J Cardiol 1999;83:55D-63D. (Pubitemid 29125682)
138. Steinberg JS, Martins J, Sadanandan S, Goldner B, Menchavez E, Domanski M et al. Antiarrhythmic drug use in the implantable defibrillatorarm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) study. Am Heart J 2001;142:520-9. (Pubitemid 32801639)
139. Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the optic study: a randomized trial. J Am Med Assoc 2006;295:165-71. (Pubitemid 43076435)
140. Pacifico A, Hohnloser SH, Williams JH, Tao B, Saksena S, Henry PD et al. Prevention of implantable-defibrillator shocks by treatment with sotalol. D,l-sotalol implantable cardioverter-defibrillator study group. N Engl J Med 1999;340:1855-62. (Pubitemid 29272665)
141. Seidl K, Hauer B, Schwick NG, Zahn R, Senges J. Comparison of metoprolol and sotalol in preventing ventricular tachyarrhythmias after the implantation of a cardioverter/defibrillator. Am J Cardiol 1998;82:744-8.
142. Kowey PR, Crijns HJ, Aliot EM, Capucci A, Kulakowski P, Radzik D et al. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the alphee study. Circulation 2011;124:2649-60.
143. Bokhari F, Newman D, Greene M, Korley V, Mangat I, Dorian P. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: elevenyear follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation 2004;110:112-6. (Pubitemid 38924577)
144. Pinter A, Akhtari S, O'Connell T, O'Donnell S, Mangat I, Korley V et al. Efficacy and safety of dofetilide in the treatment of frequent ventricular tachyarrhythmias after amiodarone intolerance or failure. J Am Coll Cardiol 2011;57:380-1.
145. Gao D, Sapp JL. Electrical storm: definitions, clinical importance, and treatment. Curr Opin Card 2013;28:72-9.
146. Lee SD, Newman D, Ham M, Dorian P. Electrophysiologic mechanisms of antiarrhythmic efficacy of a sotalol and class Ia drug combination: elimination of reverse use dependence. J Am Coll Cardiol 1997;29:100-5. (Pubitemid 27028726)
147. Van Herendael H, Pinter A, Ahmad K, Korley V, Mangat I, Dorian P. Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators. Europace 2010;12:618-25.
148. Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007;357:2657-65.
149. Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacretaz E et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 2010;375:31-40.
150. Calkins H, Epstein A, Packer D, Arria AM, Hummel J, Gilligan DM et al.; Cooled RF Multi Center Investigators Group. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study. J Am Coll Cardiol 2000;35:1905-14. (Pubitemid 30342874)
151. Mallidi J, Nadkarni GN, Berger RD, Calkins H, Nazarian S. Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease. Heart Rhythm 2011;8:503-10.
152. Piers SR, Tao Q, van Huls van Taxis CF, Schalij MJ, van der Geest RJ, Zeppenfeld K. Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: implications for the ablation strategy. Circ Arrhythm Electrophysiol 2013;54:799-808.
153. Moraes GL, Higgins CB, Ordovas KG. Delayed enhancement magnetic resonance imaging in nonischemic myocardial disease. J Thorac Imaging 2013;28:84-92, quiz 93-85.
154. Cano O, Hutchinson M, Lin D, Garcia F, Zado E, Bala R et al. Electroanatomic substrate and ablation outcome for suspected epicardial ventricular tachycardia in left ventricular nonischemic cardiomyopathy. J Am Coll Cardiol 2009;54:799-808.
155. Soejima K, Stevenson WG, Sapp JL, Selwyn AP, Couper G, Epstein LM. Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars. J Am Coll Cardiol 2004;43:1834-42. (Pubitemid 38622524)
156. Hsia HH, Callans DJ, Marchlinski FE. Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation 2003;108:704-10. (Pubitemid 36999255)
157. Nakahara S, Tung R, Ramirez RJ, Michowitz Y, Vaseghi M, Buch E et al. Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia. J Am Coll Cardiol 2010;55:2355-65.
158. Wissner E, Stevenson WG, Kuck KH. Catheter ablation of ventricular tachycardia in ischaemic and non-ischaemic cardiomyopathy: where are we today? A clinical review. Eur Heart J 2012;33:1440-50.
159. El-Damaty A, Sapp JL. The role of catheter ablation for ventricular tachycardia in patients with ischemic heart disease. Curr Opin Cardiol 2011;26:30-9.
160. Dessertenne F. [ventricular tachycardia with 2 variable opposing foci]. Arch Mal Coeur Vaiss 1966;59:263-72.
161. Kay GN, Plumb VJ, Arciniegas JG, Henthorn RW, Waldo AL. Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients. J Am Coll Cardiol 1983;2:806-17. (Pubitemid 14227254)
162. Soreide E, Morrison L, Hillman K, Monsieurs K, Sunde K, Zideman D et al. The formula for survival in resuscitation. Resuscitation 2013;346:557-63.
163. Nolan JP, Neumar RW, Adrie C, Aibiki M, Berg RA, Bottiger BW et al. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A scientific statement from the international liaison committee on resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the council on cardiovascular surgery and anesthesia; the council on cardiopulmonary, perioperative, and critical care; the council on clinical cardiology; the council on stroke. Resuscitation 2008;79:350-79.
164. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002;346:557-63. (Pubitemid 34438816)
165. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002;346:549-56.
166. Field JM, Hazinski MF, Sayre MR, Chameides L, Schexnayder SM, Hemphill R et al. Part 1: executive summary: 2010 American Heart Association Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2010;122:S640-56.
167. Hollenbeck RD, McPherson JA, Mooney MR, Unger BT, Patel NC, McMullan PW Jr et al. Early cardiac catheterization is associated with improved survival in comatose survivors of cardiac arrest without stemi. Resuscitation 2013;61:164-72.
168. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D et al. Brugada syndrome: report of the second consensus conference. Heart Rhythm 2005;2:429-40. (Pubitemid 40439292)
169. Gourraud JB, Le Scouarnec S, Sacher F, Chatel S, Derval N, Portero V et al. Identification of large families in early repolarization syndrome. J Am Coll Cardiol 2013;61:164-72.
170. Haissaguerre M, Lemetayer P, Montserrat P, Massiere JP, Warin JF. [Post-extrasystolic long QT: evaluation and significance]. Ann Cardiol Angeiol 1991;40:15-22.
171. Findler M, Birger A, Diamant S, Viskin S. Effects of head-up tilt-table test on the qt interval. Ann Noninvasive Electrocardiol 2010;15:245-9.
172. Napolitano C, Bloise R, Monteforte N, Priori SG. Sudden cardiac death and genetic ion channelopathies: long QT, brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation. Circulation 2012;125:2027-34.
173. Prystowsky EN, Padanilam BJ, Joshi S, Fogel RI. Ventricular arrhythmias in the absence of structural heart disease. J Am Coll Cardiol 2012;59:1733-44.
174. Kaufman ES. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome. Heart Rhythm 2009;6:S51-5.
175. Hofman N, van Lochem LT, Wilde AA. Genetic basis of malignant channelopathies and ventricular fibrillation in the structurally normal heart. Future Cardiol 2010;6:395-408.
176. Krahn AD, Healey JS, Chauhan V, Birnie DH, Simpson CS, Champagne J et al. Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER). Circulation 2009;120:278-85.
177. Schwartz PJ, Priori SG, Locati EH, Napolitano C, Cantu F, Towbin JA et al. Long QT syndrome patients with mutations of the scn5a and herg genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation 1995;92:3381-6.
178. Swan H, Viitasalo M, Piippo K, Laitinen P, Kontula K, Toivonen L. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with kvlqt1 and herg potassium channel defects. J Am Coll Cardiol 1999;34:823-9. (Pubitemid 29436190)
179. Sy RW, van der Werf C, Chattha IS, Chockalingam P, Adler A, Healey JS et al. Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands. Circulation 2011;124:2187-94.
180. Horner JM, Horner MM, Ackerman MJ. The diagnostic utility of recovery phase qtc during treadmill exercise stress testing in the evaluation of long QT syndrome. Heart Rhythm 2011;8:1698-704.
181. Makimoto H, Nakagawa E, Takaki H, Yamada Y, Okamura H, Noda T et al. Augmented ST-segment elevation during recovery from exercise predicts cardiac events in patients with brugada syndrome. J Am Coll Cardiol 2010;56:1576-84.
182. Krahn AD, Gollob M, Yee R, Gula LJ, Skanes AC, Walker BD et al. Diagnosis of unexplained cardiac arrest: role of adrenaline and procainamide infusion. Circulation 2005;112:2228-34. (Pubitemid 41464564)
183. Shimizu W, Noda T, Takaki H, Kurita T, Nagaya N, Satomi K et al. Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. J Am Coll Cardiol 2003;41:633-42. (Pubitemid 36223330)
184. Shimizu W, Noda T, Takaki H, Nagaya N, Satomi K, Kurita T et al. Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. Heart Rhythm 2004;1:276-83. (Pubitemid 39549754)
185. Vyas H, Ackerman MJ. Epinephrine QT stress testing in congenital long QT syndrome. J Electrocardiol 2006;39:S107-13. (Pubitemid 44465954)
186. Haissaguerre M, Le Metayer P, D'Ivernois C, Barat JL, Montserrat P, Warin JF. Distinctive response of arrhythmogenic right ventricular disease to high dose isoproterenol. Pacing Clin Electrophysiol 1990;13:2119-26.
187. Perrot B, Clozel JP, Faivre G. Effect of adenosine triphosphate on the accessory pathways. Eur Heart J 1984;5:382-93. (Pubitemid 14102186)
188. Brenyo A, Pietrasik G, Barsheshet A, Huang DT, Polonsky B, McNitt S et al. QRS fragmentation and the risk of sudden cardiac death in MADIT II. J Cardiovasc Electrophysiol 2012;23:1343-8.
189. Teodorescu C, Reinier K, Uy-Evanado A, Navarro J, Mariani R, Gunson K et al. Prolonged QRS duration on the resting ECG is associated with sudden death risk in coronary disease, independent of prolonged ventricular repolarization. Heart Rhythm 2011;8:1562-7.
190. Miyake CY, Webster G, Czosek RJ, Kantoch MJ, Dubin AM, Avasarala K et al. Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate. Circ Arrhythm Electrophysiol 2013;6:579-87.
191. Priori SG, Napolitano C, Schwartz PJ, Grillo M, Bloise R, Ronchetti E et al. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. J Am Med Assoc 2004;292:1341-4. (Pubitemid 39223225)
192. Vincent GM, Schwartz PJ, Denjoy I, Swan H, Bithell C, Spazzolini C et al. High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment 'failures'. Circulation 2009;119:215-21.
193. Hayashi M, Denjoy I, Extramiana F, Maltret A, Buisson NR, Lupoglazoff JM et al. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Circulation 2009;119:2426-34.
194. Belhassen B, Glick A, Viskin S. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation 2004;110:1731-7. (Pubitemid 39299213)
195. Belhassen B, Viskin S, Fish R, Glick A, Setbon I, Eldar M. Effects of electrophysiologic-guided therapy with class ia antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome. J Cardiovasc Electrophysiol 1999;10:1301-12. (Pubitemid 29468567)
196. Giustetto C, Schimpf R, Mazzanti A, Scrocco C, Maury P, Anttonen O et al. Long-term follow-up of patients with short QT syndrome. J Am Coll Cardiol 2011;58:587-95.
197. Haissaguerre M, Sacher F, Nogami A, Komiya N, Bernard A, Probst V et al. Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. J Am Coll Cardiol 2009;53:612-9.
198. Rosso R, Kalman JM, Rogowski O, Diamant S, Birger A, Biner S et al. Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2007;4:1149-54. (Pubitemid 47324118)
199. Swan H, Laitinen P, Kontula K, Toivonen L. Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with ryr2 mutations. J Cardiovasc Electrophysiol 2005;16:162-6. (Pubitemid 40326272)
200. van derWerf C, Kannankeril PJ, Sacher F, Krahn AD, Viskin S, Leenhardt A et al. Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol 2011;57:2244-54.
201. Moss AJ, Windle JR, Hall WJ, Zareba W, Robinson JL, McNitt S et al. Safety and efficacy of flecainide in subjects with long QT-3 syndrome (deltakpqmutation): a randomized, double-blind, placebo-controlled clinical trial. Ann Noninvasive Electrocardiol 2005;10:59-66. (Pubitemid 44933555)
202. Bode K, Hindricks G, Piorkowski C, Sommer P, Janousek J, Dagres N et al. Ablation of polymorphic ventricular tachycardias in patients with structural heart disease. Pacing Clin Electrophysiol 2008;31:1585-91.
203. Nogami A. Purkinje-related arrhythmias part ii: polymorphic ventricular tachycardia and ventricular fibrillation. Pacing Clin Electrophysiol 2011;34:1034-49.
204. Haissaguerre M, Extramiana F, Hocini M, Cauchemez B, Jais P, Cabrera JA et al. Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes. Circulation 2003;108:925-8. (Pubitemid 37048219)
205. Haissaguerre M, Shoda M, Jais P, Nogami A, Shah DC, Kautzner J et al. Mapping and ablation of idiopathic ventricular fibrillation. Circulation 2002;106:962-7. (Pubitemid 34925331)
206. Kaneshiro T, Naruse Y, Nogami A, Tada H, Yoshida K, Sekiguchi Y et al. Successful catheter ablation of bidirectional ventricular premature contractions triggering ventricular fibrillation in catecholaminergic polymorphic ventricular tachycardia with ryr2 mutation. Circ Arrhythm Electrophysiol 2012;5:e14-7.
207. Haissaguerre M, Shah DC, Jais P, Shoda M, Kautzner J, Arentz T et al. Role of purkinje conducting system in triggering of idiopathic ventricular fibrillation. Lancet 2002;359:677-8. (Pubitemid 34203772)
208. Uemura T, Yamabe H, Tanaka Y, Morihisa K, Kawano H, Kaikita K et al. Catheter ablation of a polymorphic ventricular tachycardia inducing monofocal premature ventricular complex. Intern Med 2008;47:1799-802.
209. Sacher F, Jesel L, Jais P, Haïssaguerre M. Insight into the mechanism of Brugada syndrome: epicardial substrate and modification during ajmaline testing. Heart Rhythm 2014;11:732-4.
210. Nademanee K, Veerakul G, Chandanamattha P, Chaothawee L, Ariyachaipanich A, Jirasirirojanakorn K et al. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation 2011;123:1270-9.
211. Sacher F, Wright M, Derval N, Denis A, Ramoul K, Roten L et al. Endocardial versus epicardial ventricular radiofrequency ablation: utility of in vivo contact force assessment. Circ Arrhythm Electrophysiol 2013;6:144-50.
212. Della Bella P, Baratto F, Tsiachris D, Trevisi N, Vergara P, Bisceglia C et al. Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: long-term outcome after ablation. Circulation 2013;127:1359-68.
213. Nademanee K, Taylor R, Bailey WE, Rieders DE, Kosar EM. Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation 2000;102:742-7. (Pubitemid 30643282)
214. Deneke T, Lemke B, Mugge A, Shin DI, Grewe PH, Horlitz M et al. Catheter ablation of electrical storm. Expert Rev Cardiovasc Ther 2011;9:1051-8.
215. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Part 6: advanced cardiovascular life support: Section 5: pharmacology i: agents for arrhythmias. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation 2000;102:I112-128.
216. Bourke T, Vaseghi M, Michowitz Y, Sankhla V, Shah M, Swapna N et al. Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation. Circulation 2010;121:2255-62.
217. Grimaldi R, de Luca A, Kornet L, Castagno D, Gaita F. Can spinal cord stimulation reduce ventricular arrhythmias? Heart Rhythm 2012;9:1884-7.
218. Bansch D, Bocker D, Brunn J, Weber M, Breithardt G, Block M. Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators. J Am Coll Cardiol 2000;36:566-73. (Pubitemid 30624021)
219. Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverter- defibrillators: incidence, management and prognostic implications. J Am Coll Cardiol 1998;32:1909-15. (Pubitemid 29010454)
220. Exner DV, Pinski SL, Wyse DG, Renfroe EG, Follmann D, Gold M et al. Electrical storm presages nonsudden death: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Circulation 2001;103:2066-71. (Pubitemid 32373009)
221. Fries R, Heisel A, Huwer H, Nikoloudakis N, Jung J, Schafers HJ et al. Incidence and clinical significance of short-term recurrent ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillator. Int J Cardiol 1997;59:281-4. (Pubitemid 27240463)
222. Greene M, Newman D, Geist M, Paquette M, Heng D, Dorian P. Is electrical storm in icd patients the sign of a dying heart? Outcome of patients with clusters of ventricular tachyarrhythmias. Europace 2000;2:263-9.
223. Kowey PR, Levine JH, Herre JM, Pacifico A, Lindsay BD, Plumb VJ et al.; The Intravenous Amiodarone Multicenter Investigators Group. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. Circulation 1995;92:3255-63.
224. Verma A, Kilicaslan F, Marrouche NF, Minor S, Khan M, Wazni O et al. Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm. J Cardiovasc Electrophysiol 2004;15:1265-70. (Pubitemid 39612632)
225. Brigadeau F, Kouakam C, Klug D, Marquie C, Duhamel A, Mizon-Gerard F et al. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators. Eur Heart J 2006;27:700-7.
226. Hariman RJ, Hu DY, Gallastegui JL, Beckman KJ, Bauman JL. Long-term follow-up in patients with incessant ventricular tachycardia. Am J Cardiol 1990;66:831-6. (Pubitemid 20352263)
227. Gatzoulis KA, Andrikopoulos GK, Apostolopoulos T, Sotiropoulos E, Zervopoulos G, Antoniou J et al. Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy. Europace 2005;7:184-92. (Pubitemid 40347865)
228. Wood MA, Simpson PM, Stambler BS, Herre JM, Bernstein RC, Ellenbogen KA. Long-term temporal patterns of ventricular tachyarrhythmias. Circulation 1995;91:2371-7.
229. Brodine WN, Tung RT, Lee JK, Hockstad ES, Moss AJ, Zareba W et al. Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the multicenter automatic defibrillator implantation trial-ii). Am J Cardiol 2005;96:691-5. (Pubitemid 41207315)
230. Nazarian S, Bluemke DA, Lardo AC, Zviman MM, Watkins SP, Dickfeld TL et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 2005;112:2821-5. (Pubitemid 41641676)
231. Nakahara S, Chien C, Gelow J, Dalouk K, Henrikson CA, Mudd J et al. Ventricular arrhythmias after left ventricular assist device. Circ Arrhythm Electrophysiol 2013;6:648-54.
232. Guerra F, Shkoza M, Scappini L, Flori M, Capucci A. Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors: a meta-analysis. Europace 2014;16:347-53
233. Ziv O, Dizon J, Thosani A, Naka Y, Magnano AR, Garan H. Effects of left ventricular assist device therapy on ventricular arrhythmias. J Am Coll Cardiol 2005;45:1428-34. (Pubitemid 40615614)
234. Garan AR, Yuzefpolskaya M, Colombo PC, Morrow JP, Te-Frey R, Dano D et al. Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention?. J Am Coll Cardiol 2013;61:2542-50.
235. Raasch H, Jensen BC, Chang PP, Mounsey JP, Gehi AK, Chung EH et al. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation. Am Heart J 2012;164:373-8.
236. Harding JD, Piacentino V III, Rothman S, Chambers S, Jessup M, Margulies KB. Prolonged repolarization after ventricular assist device support is associated with arrhythmias in humans with congestive heart failure. J Card Fail 2005;11:227-32. (Pubitemid 40462427)
237. Bedi M, Kormos R, Winowich S, McNamara DM, Mathier MA, Murali S. Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol 2007;99:1151-3. (Pubitemid 46562514)
238. Cantillon DJ, Bianco C, Wazni OM, Kanj M, Smedira NG, Wilkoff BL et al. Electrophysiologic characteristics and catheter ablation of ventricular tachyarrhythmias among patients with heart failure on ventricular assist device support. Heart Rhythm 2012;9:859-64.
239. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007;357:885-96. (Pubitemid 47347322)
240. Kuhne M, Sakumura M, Reich SS, Sarrazin JF, Wells D, Chalfoun N et al. Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure. Am J Cardiol 2010;105:378-82.
241. Refaat M, Chemaly E, Lebeche D, Gwathmey JK, Hajjar RJ. Ventricular arrhythmias after left ventricular assist device implantation. Pacing Clin Electrophysiol 2008;31:1246-52.
242. Shirazi JT, Lopshire JC, Gradus-Pizlo I, Hadi MA, Wozniak TC, Malik AS. Ventricular arrhythmias in patients with implanted ventricular assist devices: a contemporary review. Europace 2013;15:11-7.
243. Brenyo A, Rao M, Koneru S, Hallinan W, Shah S, Massey HT et al. Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients. J Cardiovasc Electrophysiol 2012;23:515-20.
244. Andersen M, Videbaek R, Boesgaard S, Sander K, Hansen PB, Gustafsson F. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (heartmate ii). J Heart Lung Transplant 2009;28:733-5.
245. Dandamudi G, Ghumman WS, Das MK, Miller JM. Endocardial catheter ablation of ventricular tachycardia in patients with ventricular assist devices. Heart Rhythm 2007;4:1165-9. (Pubitemid 47324123)
246. Osaki S, Alberte C, Murray MA, Brahmbhatt RD, Johnson MR, Edwards NM et al. Successful radiofrequency ablation therapy for intractable ventricular tachycardia with a ventricular assist device. J Heart Lung Transplant 2008;27:353-6. (Pubitemid 351375104)
247. Valderrabano M, Dave AS, Baez-Escudero JL, Rami T. Robotic catheter ablation of left ventricular tachycardia: initial experience. Heart Rhythm 2011;8:1837-46.
248. Herweg B, Ilercil A, Sheffield CD, Caldeira CC, Rinde-Hoffman D, Barold SS. Ablation of left ventricular tachycardia via transeptal approach and crossing of a mechanical mitral valve prosthesis. Pacing Clin Electrophysiol 2010;33:900-3.
249. Emaminia A, Nagji AS, Ailawadi G, Bergin JD, Kern JA. Concomitant left ventricular assist device placement and cryoablation for treatment of ventricular tachyarrhythmias associated with heart failure. Ann Thorac Surg 2011;92:334-6.
250. Mulloy DP, Bhamidipati CM, Stone ML, Ailawadi G, Bergin JD, Mahapatra S et al. Cryoablation during left ventricular assist device implantation reduces postoperative ventricular tachyarrhythmias. J Thorac Cardiovasc Surg 2013;145:1207-13.
251. Wolfe RR, Driscoll DJ, Gersony WM, Hayes CJ, Keane JF, Kidd L et al. Arrhythmias in patients with valvar aortic stenosis, valvar pulmonary stenosis, and ventricular septal defect. Results of 24-hour ECG monitoring. Circulation 1993;87(Suppl):I89-101.
252. Walsh EP, Rockenmacher S, Keane JF, Hougen TJ, Lock JE, Castaneda AR. Late results in patients with tetralogy of fallot repaired during infancy. Circulation 1988;77:1062-7.
253. Wernovsky G, Hougen TJ, Walsh EP, Sholler GF, Colan SD, Sanders SP et al. Midterm results after the arterial switch operation for transposition of the great arteries with intact ventricular septum: clinical, hemodynamic, echocardiographic, and electrophysiologic data [published erratum appears in Circulation 1988 Aug;78(2):A5]. Circulation 1988;77:1333-44.
254. Gillette PC, Yeoman MA, Mullins CE, McNamara DG. Sudden death after repair of tetralogy of Fallot. Electrocardiographic and electrophysiologic abnormalities. Circulation 1977;56(Pt 1):566-71. (Pubitemid 8210021)
255. Abrams DJ, Earley MJ, Sporton SC, Kistler PM, Gatzoulis MA, Mullen MJ et al. Comparison of noncontact and electroanatomic mapping to identify scar and arrhythmia late after the fontan procedure. Circulation 2007;115:1738-46. (Pubitemid 46648610)
256. Roos-Hesselink J, Perlroth MG, McGhie J, Spitaels S. Atrial arrhythmias in adults after repair of tetralogy of Fallot. Correlations with clinical, exercise, and echocardiographic findings. Circulation 1995;91:2214-9.
257. Khairy P, Van Hare GF, Balaji S, Berul CI, Cecchin F, Cohen MI et al. Paces/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: executive summary. Heart Rhythm 2014.
258. Khairy P, Van Hare GF, Balaji S, Berul CI, Cecchin F, Cohen MI et al. Paces/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease. Heart Rhythm 2014;31:1220-9.
259. Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, van Dijk AP et al. Mortality in adult congenital heart disease. Eur Heart J 2010;31:1220-9.
260. Oechslin EN, Harrison DA, Connelly MS, Webb GD, Siu SC. Mode of death in adults with congenital heart disease. Am J Cardiol 2000;86:1111-6.
261. Silka MJ, Hardy BG, Menashe VD, Morris CD. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 1998;32:245-51. (Pubitemid 28351069)
262. Nollert GD, Dabritz SH, Schmoeckel M, Vicol C, Reichart B. Risk factors for sudden death after repair of tetralogy of Fallot. Ann Thorac Surg 2003;76:1901-5. (Pubitemid 37510501)
263. Nollert G, Fischlein T, Bouterwek S, Bohmer C, Klinner W, Reichart B. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol 1997;30:1374-83.
264. Nollert G, Fischlein T, Bouterwek S, Bohmer C, Dewald O, Kreuzer E et al. Long-term results of total repair of tetralogy of fallot in adulthood: 35 years follow-up in 104 patients corrected at the age of 18 or older. Thorac Cardiovasc Surg 1997;45:178-81. (Pubitemid 27396087)
265. Gallego P, Gonzalez AE, Sanchez-Recalde A, Peinado R, Polo L, Gomez-Rubin C et al. Incidence and predictors of sudden cardiac arrest in adults with congenital heart defects repaired before adult life. Am J Cardiol 2012;110:109-17.
266. Khairy P, Landzberg MJ, Gatzoulis MA, Lucron H, Lambert J, Marcon F et al. Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study. Circulation 2004;109:1994-2000. (Pubitemid 38544490)
267. Khairy P. Programmed ventricular stimulation for risk stratification in patients with tetralogy of Fallot: a Bayesian perspective. Nat Clin Pract Cardiovasc Med 2007;4:292-3. (Pubitemid 46860542)
268. Chandar JS, Wolff GS, Garson A Jr, Bell TJ, Beder SD, Bink-Boelkens M et al. Ventricular arrhythmias in postoperative tetralogy of Fallot. Am J Cardiol 1990;65:655-61. (Pubitemid 20091896)
269. Balaji S, Lau YR, Case CL, Gillette PC. QRS prolongation is associated with inducible ventricular tachycardia after repair of tetralogy of Fallot. Am J Cardiol 1997;80:160-3. (Pubitemid 27329214)
270. Khairy P, Landzberg MJ. Adult congenital heart disease: toward prospective risk assessment of a multisystemic condition. Circulation 2008;117:2311-2. (Pubitemid 351681555)
271. Tsai SF, Chan DP, Ro PS, Boettner B, Daniels CJ. Rate of inducible ventricular arrhythmia in adults with congenital heart disease. Am J Cardiol 2010;106:730-6.
272. The TRACE Study Group. The Trandolapril Cardiac Evaluation (TRACE) Study: rationale, design and baseline characteristics of the screened population. Am J Cardiol 1994;73:44c-50c.
273. Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NA III et al.; American College of Cardiology F, American Heart Association Task Force on Practice G, Heart Rhythm S. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society [corrected]. Circulation 2012;126:1784-800.
274. Silversides CK, Dore A, Poirier N, Taylor D, Harris L, Greutmann M et al. Canadian cardiovascular society 2009 consensus conference on the management of adults with congenital heart disease: shunt lesions. Can J Cardiol 2010;26:e70-9.
275. Alexander ME, Walsh EP, Saul JP, Epstein MR, Triedman JK. Value of programmed ventricular stimulation in patients with congenital heart disease. J Cardiovasc Electrophysiol 1999;10:1033-44.
276. Koyak Z, de Groot JR, Bouma BJ, Van Gelder IC, Budts W, Zwinderman AH et al. Symptomatic but not asymptomatic non-sustained ventricular tachycardia is associated with appropriate implantable cardioverter therapy in tetralogy of fallot. Int J Cardiol 2012;99:1462-7.
277. Giardini A, Specchia S, Tacy TA, Coutsoumbas G, Gargiulo G, Donti A et al. Usefulness of cardiopulmonary exercise to predict long-term prognosis in adults with repaired tetralogy of Fallot. Am J Cardiol 2007;99:1462-7. (Pubitemid 46686646)
278. Fernandes SM, Alexander ME, Graham DA, Khairy P, Clair M, Rodriguez E et al. Exercise testing identifies patients at increased risk for morbidity and mortality following fontan surgery. Congenit Heart Dis 2011;6:294-303.
279. Khairy P, Harris L, Landzberg MJ, Fernandes SM, Barlow A, Mercier LA et al. Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study. Circ Arrhythm Electrophysiol 2008;1:250-7.
280. Lucron H, Marcon F, Bosser G, Lethor JP, Marie PY, Brembilla-Perrot B. Induction of sustained ventricular tachycardia after surgical repair of tetralogy of fallot. Am J Cardiol 1999;83:1369-73. (Pubitemid 29205748)
281. Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua LM, Berul CI. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol 2004;15:72-6. (Pubitemid 38147223)
282. Geva T, Sandweiss BM, Gauvreau K, Lock JE, Powell AJ. Factors associated with impaired clinical status in long-term survivors of tetralogy of fallot repair evaluated by magnetic resonance imaging. J Am Coll Cardiol 2004;43:1068-74. (Pubitemid 38352990)
283. Knauth AL, Gauvreau K, Powell AJ, Landzberg MJ, Walsh EP, Lock JE et al. Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of fallot repair. Heart 2008;94:211-6. (Pubitemid 351211733)
284. Alexander ME, Cecchin F, Huang KP, Berul CI. Microvolt t-wave alternans with exercise in pediatrics and congenital heart disease: limitations and predictive value. Pacing Clin Electrophysiol 2006;29:733-41. (Pubitemid 44060741)
285. Fish FA, Gillette PC, Benson DW Jr.; The Pediatric Electrophysiology Group. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. J Am Coll Cardiol 1991;18:356-65.
286. Thorne SA, Barnes I, Cullinan P, Somerville J. Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease. Circulation 1999;100:149-54. (Pubitemid 29330013)
287. Brugada J, Blom N, Sarquella-Brugada G, Blomstrom-Lundqvist C, Deanfield J, Janousek J et al. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group Joint Consensus Statement. Europace 2013;112:3470-7.
288. Saul JP, Scott WA, Brown S, Marantz P, Acevedo V, Etheridge SP et al. Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, doubleblind, antiarrhythmic drug trial. Circulation 2005;112:3470-7. (Pubitemid 43739563)
289. Morwood JG, Triedman JK, Berul CI, Khairy P, Alexander ME, Cecchin F et al. Radiofrequency catheter ablation of ventricular tachycardia in children and young adults with congenital heart disease. Heart Rhythm 2004;1:301-8. (Pubitemid 39549759)
290. Gonska BD, Cao K, Raab J, Eigster G, Kreuzer H. Radiofrequency catheter ablation of right ventricular tachycardia late after repair of congenital heart defects. Circulation 1996;94:1902-8. (Pubitemid 26349303)
291. Biblo LA, Carlson MD. Transcatheter radiofrequency ablation of ventricular tachycardia following surgical correction of tetralogy of fallot. Pacing Clin Electrophysiol 1994;17:1556-60. (Pubitemid 24271509)
292. Fukuhara H, Nakamura Y, Tasato H, Tanihira Y, Baba K, Nakata Y. Successful radiofrequency catheter ablation of left ventricular tachycardia following surgical correction of tetralogy of Fallot. Pacing Clin Electrophysiol 2000;23:1442-5.
293. Furushima H, Chinushi M, Sugiura H, Komura S, Tanabe Y, Watanabe H et al. Ventricular tachycardia late after repair of congenital heart disease: efficacy of combination therapy with radiofrequency catheter ablation and class iii antiarrhythmic agents and long-term outcome. J Electrocardiol 2006;39:219-24.
294. Yokokawa M, Good E, Crawford T, Chugh A, Pelosi F Jr, Latchamsetty R et al. Recovery from left ventricular dysfunction after ablation of frequent premature ventricular complexes. Heart Rhythm 2013;10:172-5.
295. Zeppenfeld K, Schalij MJ, Bartelings MM, Tedrow UB, Koplan BA, Soejima K et al. Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus. Circulation 2007;116:2241-52. (Pubitemid 350100329)
296. Mavroudis C, Deal BJ, Backer CL, Tsao S. Arrhythmia surgery in patients with and without congenital heart disease. Ann Thorac Surg 2008;86:857-68; discussion 857-868.
297. Kalra Y, Radbill AE, Johns JA, Fish FA, Kannankeril PJ. Antitachycardia pacing reduces appropriate and inappropriate shocks in children and congenital heart disease patients. Heart Rhythm 2012;9:1829-34.
298. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA et al.; American College of C, American Heart Association Task Force on Practice G, American Society of E, Heart Rhythm S, International Society for Adult Congenital Heart D, Society for Cardiovascular A, Interventions, Society of Thoracic S. ACC/AHA2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;52:e143-263.
299. Harrild DM, Berul CI, Cecchin F, Geva T, Gauvreau K, Pigula F et al. Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia. Circulation 2009;119:445-51.
300. Harrison DA, Harris L, Siu SC, MacLoghlin CJ, Connelly MS, Webb GD et al. Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot. J Am Coll Cardiol 1997;30:1368-73. (Pubitemid 27501459)
301. Karamlou T, Silber I, Lao R, McCrindle BW, Harris L, Downar E et al. Outcomes after late reoperation in patients with repaired tetralogy of Fallot: the impact of arrhythmia and arrhythmia surgery. Ann Thorac Surg 2006;81:1786-93. (Pubitemid 350030028)
302. Crosson JE, Callans DJ, Bradley DJ, Dubin A, Epstein M, Etheridge S et al. Paces/HRS expert consensus statement on evaluation and management of ventricular arrhythmias in the child with a structurally normal heart. Heart Rhythm 2014;125:1684-94.